Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic natural killer cells (1 trial)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Trials (1 total)
Trial APIs (1 total)